Biomerica Stock Analysis

Biomerica Stock Analysis Notes

About 27.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biomerica recorded a loss per share of 0.37. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 14th of November 1994. Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Biomerica operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 64 people. For more info on Biomerica please contact Zackary Irani at (949) 645-2111 or go to https://www.biomerica.com.

Biomerica Investment Alerts

Biomerica Upcoming and Recent Events

Biomerica Largest EPS Surprises

View All Earnings Estimates

Biomerica Stock Institutional Investors

Note, although Biomerica's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biomerica Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerica's market, we take the total number of its shares issued and multiply it by Biomerica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biomerica Profitablity

The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.97) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.97.

Management Efficiency

Biomerica has return on total asset (ROA) of (0.4302) % which means that it has lost $0.4302 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9205) %, meaning that it created substantial loss on money invested by shareholders. Biomerica's management efficiency ratios could be used to measure how well Biomerica manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.55. The current year's Return On Capital Employed is expected to grow to -0.63. At present, Biomerica's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 273.8 K, whereas Non Current Assets Total are forecasted to decline to about 1.3 M.

Technical Drivers

As of the 24th of April, Biomerica shows the Standard Deviation of 4.23, risk adjusted performance of (0.03), and Mean Deviation of 3.15. Biomerica technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Biomerica, which can be compared to its peers. Please confirm Biomerica variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Biomerica is priced correctly, providing market reflects its regular price of 0.72 per share. As Biomerica is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Biomerica Price Movement Analysis

Biomerica Insider Trading Activities

Biomerica Predictive Daily Indicators

Biomerica Forecast Models

Biomerica's time-series forecasting models are one of many Biomerica's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomerica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biomerica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biomerica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biomerica. By using and applying Biomerica Stock analysis, traders can create a robust methodology for identifying Biomerica entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biomerica analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biomerica analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Biomerica stock analysis indicators help investors evaluate how Biomerica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biomerica shares will generate the highest return on investment. By understating and applying Biomerica stock analysis, traders can identify Biomerica position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.

Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.